{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:51:25Z","timestamp":1779223885867,"version":"3.51.4"},"reference-count":12,"publisher":"Hindawi Limited","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1188,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Diabetes"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1111\/j.1399-5448.2012.00873.x","type":"journal-article","created":{"date-parts":[[2012,5,31]],"date-time":"2012-05-31T10:48:41Z","timestamp":1338461321000},"page":"578-582","source":"Crossref","is-referenced-by-count":7,"title":["Time to failure of oral therapy in children with type 2 diabetes: a single center retrospective chart review"],"prefix":"10.1155","volume":"13","author":[{"given":"Nicole S.","family":"Barnes","sequence":"first","affiliation":[{"name":"Division of Pediatric Endocrinology; University of Texas Southwestern Medical Center at Dallas; Dallas; TX; USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perrin C.","family":"White","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology; University of Texas Southwestern Medical Center at Dallas; Dallas; TX; USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele R.","family":"Hutchison","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology; University of Texas Southwestern Medical Center at Dallas; Dallas; TX; USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2012,5,31]]},"reference":[{"key":"10.1111\/j.1399-5448.2012.00873.x-BIB0001|pedi873-cit-0001","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1542\/peds.2006-0690","article-title":"The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study","volume":"118","author":"Liese","year":"2006","journal-title":"Pediatrics"},{"key":"10.1111\/j.1399-5448.2012.00873.x-BIB0002|pedi873-cit-0002","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/jama.290.14.1884","article-title":"Lifetime risk for diabetes mellitus in the United States","volume":"13","author":"Narayan","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1399-5448.2012.00873.x-BIB0003|pedi873-cit-0003","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1515\/JPEM.2004.17.6.871","article-title":"Type 1 and type 2 diabetes mellitus in childhood in the United States: practice patterns by pediatric endocrinologists","volume":"17","author":"Rapaport","year":"2004","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1111\/j.1399-5448.2012.00873.x-BIB0004|pedi873-cit-0004","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/adc.2008.143313","article-title":"Management and 1\u2009year outcome for UK children with type 2 diabetes","volume":"94","author":"Shield","year":"2009","journal-title":"Arch Dis Child"},{"key":"10.1111\/j.1399-5448.2012.00873.x-BIB0005|pedi873-cit-0005","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc10-S011","article-title":"Standards of medical care in diabetes","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1399-5448.2012.00873.x-BIB0006|pedi873-cit-0006","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of Rosiglitazone, Metformin, or Glyburide Monotherapy (ADOPT)","volume":"355","author":"Kahn","year":"2006","journal-title":"NEJM"},{"key":"10.1111\/j.1399-5448.2012.00873.x-BIB0007|pedi873-cit-0007","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2337\/dc09-1749","article-title":"Secondary failure of metformin monotherapy in clinical practice","volume":"33","author":"Brown","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1399-5448.2012.00873.x-BIB0008|pedi873-cit-0008","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2337\/diacare.29.03.06.dc05-1937","article-title":"Treatment escalation and rise in HbA1c following successful initial metformin therapy","volume":"3","author":"Nichols","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1399-5448.2012.00873.x-BIB0009|pedi873-cit-0009","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulfonylurea, metformin or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS)","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"key":"10.1111\/j.1399-5448.2012.00873.x-BIB0010|pedi873-cit-0010","doi-asserted-by":"crossref","first-page":"e912","DOI":"10.1542\/peds.2007-1484","article-title":"Self-management behaviors, racial disparities, and glycemic control among adolescents with type 2 diabetes","volume":"121","author":"Rothman","year":"2008","journal-title":"Pediatrics"},{"key":"10.1111\/j.1399-5448.2012.00873.x-BIB0011|pedi873-cit-0011","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00125-005-1690-x","article-title":"Islet autoantibodies in clinically diagnosed type 2 diabetes; prevalence and relationship with metabolic control (UKPDS 70)","volume":"48","author":"Davis","year":"2005","journal-title":"Diabetologia"},{"key":"10.1111\/j.1399-5448.2012.00873.x-BIB0012|pedi873-cit-0012","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00125-005-1691-9","article-title":"IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71)","volume":"48","author":"Bottazzo","year":"2005","journal-title":"Diabetologia"}],"container-title":["Pediatric Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5448.2012.00873.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1399-5448.2012.00873.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:05:52Z","timestamp":1671818752000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5448.2012.00873.x"}},"subtitle":["Oral therapy failure in pediatric T2D"],"short-title":[],"issued":{"date-parts":[[2012,5,31]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1399-5448.2012.00873.x","relation":{},"ISSN":["1399-543X"],"issn-type":[{"value":"1399-543X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,31]]}}}